Related Experiment Videos
Influence of lornoxicam on serum pepsinogen levels
W Kullich1, G Klein, G Pöllmann
1Rehabilitation Centre for Rheumatic and Cardiovascular Diseases, Saalfelden, Austria.
Postgraduate Medical Journal
|January 1, 1990
Abstract:
Serum pepsinogen I was determined radioimmunologically in 18 patients suffering from lumbar backache syndromes. These patients were then treated with lornoxicam 4 mg twice daily over a period of 2 weeks. No significant increase in the serum pepsinogen I level was found in 17 (94.4%) of cases. Using the serum pepsinogen I as a parameter for the integrity of the gastric mucosa, this suggests good gastric tolerance of lornoxicam.